Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study
- PMID: 33212372
- DOI: 10.1016/j.drugpo.2020.103027
Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study
Abstract
Background: Monitoring drug use in México is a challenge due to emerging drugs and rapid changes in consumption patterns. The temporal and geographical patterns of cocaine, methamphetamine, amphetamine, MDMA, cannabis, heroin, ketamine, and fentanyl were examined in Mexican cities using wastewater-based epidemiology (WBE).
Methods: 105 daily composite wastewater samples were collected from sewage treatment plants in fifteen Mexican cities. We quantified drug residues using liquid chromatography-high-resolution mass spectrometry, and estimated drug use by back-calculation of drug loads.
Results: We identified ten drug target residues in at least one sample across cities. Drugs with the highest median levels were cannabis, methamphetamine, and cocaine. The median range of cannabis for one week was between 147 and 20,364 mg/day/1000inhab across cities, whereas methamphetamine ranged between 5 and 3,628 mg/day/1000inhab. Cocaine was found in levels between 2 and 370 mg/day/1000inhab. The highest levels of methamphetamine and amphetamine were observed in the US border cities of Tijuana and San Luis Río Colorado. The presence of heroin, MDMA, ketamine, and fentanyl was stronger during weekends, while cannabis, cocaine, and amphetamine were found throughout the week.
Conclusion: This study provides the first report of fentanyl, norfentanyl, and ketamine in wastewater in Mexico. The results indicate an increased presence of drugs on known drug traffic routes, demonstrating that WBE can help identify areas of high drug use and assist governments in developing policies to reduce drug use and harm in the communities.
Keywords: Drug target residue; Drug use; Fentanyl; Mexico; Wastewater-based epidemiology.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This study was approved by the Ethics, Research and Biosafety Committees at the National, Institute of Public Health (CI:1476), Copytzy Cruz-Cruz, Viviane Yargeau, Desireé Vidaña-Pérez, Astrid Schilmann Halbinger, Marco Aurelio Pineda Castro, María Margarita Lobato Calleros, Mauricio Hernández-Ávila, Jorge Ameth Villatoro Velázquez, Tonatiuh Barrientos-Gutiérrez
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
